Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 Oct 29;396(10260):1394–1395. doi: 10.1016/S0140-6736(20)32211-X

Asymptomatic health-care worker screening during the COVID-19 pandemic – Authors' reply

Thomas A Treibel a,d, Charlotte Manisty a,d, Mervyn Andiapen f, Corinna Pade g,h, Melanie Jensen d, Marianna Fontana c,i, Xosé Couto-Parada e, Teresa Cutino-Moguel e, Mahdad Noursadeghi b, James C Moon a,d
PMCID: PMC7598568  PMID: 33129388

Kevin Fennelly and Christopher Whalen emphasise that health-care workers (HCWs) are at a higher risk of severe acute respiratory syndrome coronavirus 2 infection than are the general population. Angela Chow and colleagues describe their experience in Singapore of very low rates of HCW infections and nosocomial transmission when effective personal protective equipment is implemented. We agree with both perspectives, and our Correspondence1 did not contradict either of these viewpoints.

Front-line HCWs have a reported hazard ratio of more than 3 compared with the general community.2 This risk is variable between studies, with reported seropositivity rates in the UK ranging from 6% to 43% across different hospital settings.3, 4 Explanations for this variation include confounding by sampling timepoints during an emerging epidemic wave, participant selection (random vs symptomatic), and rates of self-isolation, and differences in the nature of exposures, policies for infection control, and use of personal protective equipment.

Our study was done when symptomatic HCWs were already required to quarantine. We sought to address the need for repeated mass screening of staff without disease-defining symptoms to help to reduce transmission associated with health care. Therefore, we focused on asymptomatic or pauci-symptomatic infection in HCWs at sequential timepoints during the first epidemic wave in London, UK, sampling only HCWs who attended work because they did not meet the symptomatic criteria to self-isolate. PCR-positive results peaked one week before the PCR-positive peak in London (which was at that time reflected mainly by symptomatic patients presenting to hospitals). We inferred from this that the peak of asymptomatic infection in our HCW cohort coincided with the peak of virus circulation in the community.1 Thereafter, the rates of prevalent asymptomatic infection in our cohort reduced in line with the decline in community cases, despite a persistent number of patients with COVID-19 within the hospital. Further serial swabbing of HCWs over 16 weeks to mid-August, 2020, showed no new cases (appendix p 1) and neither did extension to two further hospitals and a total of 731 participants who were studied longitudinally (data not shown). The number of HCWs who were self-isolating fell to nearly zero over this time period. Despite some persistent hospitalised cases, zero cases were identified by PCR and nearly zero HCWs were self-quarantining by approximately 4 weeks after the peak, suggesting that nosocomial transmission had ceased. A key contributor to the absence of ongoing nosocomial transmission was likely to be the effective implementation of infection control practices.

Our approach to focus on asymptomatic infections underestimates the absolute incident rate of infections among HCWs, but it identifies the scale of infection missed by case-definition criteria and is likely to be a fair surrogate for the trend of incident infections. These data suggest that tracking community prevalence to trigger asymptomatic screening of HCWs is more informative than monitoring hospital caseloads.

Acknowledgments

Funding for the work presented in this Correspondence was donated by individuals, charitable Trusts, and corporations including Barts Charity (MRC0281), Goldman Sachs, Citadel and Citadel Securities, The Guy Foundation, GW Pharmaceuticals, Kusuma Trust, and Jagclif Charitable Trust. The funders had no role in study design, data collection, or the decision to publish this Correspondence. The corresponding author had full access to all data and final responsibility for the decision to submit for publication. JCM and CM are directly and indirectly supported by the University College London Hospitals (UCLH), Barts National Institute for Health Research (NIHR) Biomedical Research Centres and the British Heart Foundation (BHF). TAT is funded by a BHF Intermediate Research Fellowship. MN is supported by a Wellcome Trust Investigator in Science Award and the UCLH NIHR Biomedical Research Centre. All other authors declare no competing interests.

Supplementary Material

Supplementary appendix
mmc1.pdf (668.1KB, pdf)

References

  • 1.Treibel TA, Manisty C, Burton M. COVID-19: PCR screening of asymptomatic health-care workers at London hospital. Lancet. 2020;395:1608–1610. doi: 10.1016/S0140-6736(20)31100-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Nguyen LH, Drew DA, Graham MS. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020;5:e475–e483. doi: 10.1016/S2468-2667(20)30164-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Houlihan CF, Vora N, Byrne T. Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. Lancet. 2020;396:e6–e7. doi: 10.1016/S0140-6736(20)31484-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Augusto JB, Menacho K, Andiapen M. Healthcare workers bioresource: study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19. Wellcome Open Res. 2020;5:179. doi: 10.12688/wellcomeopenres.16051.1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary appendix
mmc1.pdf (668.1KB, pdf)

Articles from Lancet (London, England) are provided here courtesy of Elsevier

RESOURCES